Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques

The patients in Inclisiran group were given drugs three times in total. The first needle was injected subcutaneously with 284mg(1.5ml solution) after entering the group, the second needle was injected three months later and the third needle was injected at the ninth month.

Rosuvastatin